EyePoint (EYPT) EBT Margin Growth (5y) (2015 - 2026)
EyePoint (EYPT) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.71 Mn |
| Dec 31, 2025 | -1.06 Mn |
| Sep 30, 2025 | -615,924.00 |
| Jun 30, 2025 | -79,820.00 |
| Mar 31, 2025 | -3,772.00 |
| Dec 31, 2024 | -18,775.00 |
| Sep 30, 2024 | 35,194.00 |
| Jun 30, 2024 | -16,211.00 |
| Mar 31, 2024 | -5,612.00 |
| Dec 31, 2023 | 77,843.00 |
| Sep 30, 2023 | 122,456.00 |
| Jun 30, 2023 | 49,540.00 |
| Mar 31, 2023 | 21,814.00 |
| Dec 31, 2022 | 20,146.00 |
| Sep 30, 2022 | 66,022.00 |
| Jun 30, 2022 | -242,755.00 |
| Mar 31, 2022 | 66,104.00 |
| Dec 31, 2021 | -17,147.00 |
| Sep 30, 2021 | 240,120.00 |
| Jun 30, 2021 | 134,417.00 |